Skip to content
My WebMD Sign In, Sign Up

Alzheimer's Disease Health Center

Font Size

Experimental Alzheimer's Drug Halted

Drug Flurizan Didn't Meet Maker's Goals in Latest Tests
By
WebMD Health News
Reviewed by Louise Chang, MD

!homosexual_brain_and_opposite_sex.jpg

July 2, 2008 -- It's the end of the road for Flurizan, an experimental Alzheimer's disease drug, after disappointing results in its latest study.

Myriad Genetics, which was developing Flurizan, says it's discontinuing work on the drug.

In a preliminary study recently published in The Lancet, Flurizan looked like it might slow functional decline in Alzheimer's patients.

But in Flurizan's latest study -- an 18-month trial in patients with mild Alzheimer's disease -- Flurizan didn't meet the researchers' benchmark for its effects on cognition (mental skills) and daily activities.

Today on WebMD

alzheimer's disease warning signs
ARTICLE
Alzheimers Overview
SLIDESHOW
 
Best Memory Boosting Games
ARTICLE
mri scan of human brain
QUIZ
 
senior man
ARTICLE
daughter and father
ARTICLE
 
Making Diagnosis
Article
Colored mri of brain
ARTICLE
 
Close up of elderly couple holding hands
VIDEO
senior woman with lost expression
ARTICLE
 
Woman comforting ailing mother
ARTICLE
Alzheimers Dementia
ARTICLE